MedPath

Radiotherapy for glioblastoma: Dose escalation trial of IMRT after hyperbaric oxygen therapy

Not Applicable
Conditions
Glioblastoma
Registration Number
JPRN-UMIN000027623
Lead Sponsor
Tobata Kyoritsu Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
18
Inclusion Criteria

Not provided

Exclusion Criteria

Without brain stem invasion. Gliomatosis cerebri

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cranial nerve disorder at one, 3, 5, and 7 weeks after the treatments. CT and MR images, each 3 month after the treatments.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath